Zhejiang Dejin Biopharmaceutical Technology Co.
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- Undisclosed
Investors
- 1
About Zhejiang Dejin Biopharmaceutical Technology Co.
, Ltd. provides synthetic biopharmaceutical solutions for the healthcare industry. The company was established to apply gene engineering to the production of botulinum toxin, aiming to lower costs and improve safety compared to traditional methods. The company works with medical institutions in the medical aesthetics industry to provide advanced toxin products. The company develops recombinant botulinum toxin injections (such as DJ-01) using a proprietary gene engineering strain design platform. The company’s revenue is generated by the direct sale of its recombinant botox products to hospitals and aesthetic clinics.
Who invested in Zhejiang Dejin Biopharmaceutical Technology Co.
1 investor across 1 round
See all investors in Zhejiang Dejin Biopharmaceutical Technology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 20, 2026
Amount
Undisclosed
Investors
Questions about Zhejiang Dejin Biopharmaceutical Technology Co.
Who invested in Zhejiang Dejin Biopharmaceutical Technology Co.?
Zhejiang Dejin Biopharmaceutical Technology Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zhejiang Dejin Biopharmaceutical Technology Co. raised?
Zhejiang Dejin Biopharmaceutical Technology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Zhejiang Dejin Biopharmaceutical Technology Co. last raise money?
Zhejiang Dejin Biopharmaceutical Technology Co.'s most recent round on record is a Series A, in Jan 2026.
What does Zhejiang Dejin Biopharmaceutical Technology Co. do?
Zhejiang Dejin Biopharmaceutical Technology Co. is a biotechnology company.
Where is Zhejiang Dejin Biopharmaceutical Technology Co. headquartered?
Zhejiang Dejin Biopharmaceutical Technology Co. is headquartered in Hangzhou, China.
Which VCs invest in companies like Zhejiang Dejin Biopharmaceutical Technology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Zhejiang Dejin Biopharmaceutical Technology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Zhejiang Dejin Biopharmaceutical Technology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.